Summit Therapeutics Inc (SMMT)
19.96
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 10:27
Summit Therapeutics Max Drawdown (5Y): 95.17% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 95.17% |
| September 30, 2024 | 95.17% |
| August 31, 2024 | 95.17% |
| July 31, 2024 | 95.17% |
| June 30, 2024 | 95.17% |
| May 31, 2024 | 95.17% |
| April 30, 2024 | 95.17% |
| March 31, 2024 | 95.17% |
| February 29, 2024 | 95.17% |
| January 31, 2024 | 95.17% |
| December 31, 2023 | 95.17% |
| November 30, 2023 | 95.17% |
| October 31, 2023 | 95.17% |
| September 30, 2023 | 95.17% |
| August 31, 2023 | 95.17% |
| July 31, 2023 | 95.17% |
| June 30, 2023 | 95.17% |
| May 31, 2023 | 95.17% |
| April 30, 2023 | 95.17% |
| March 31, 2023 | 95.17% |
| February 28, 2023 | 95.17% |
| January 31, 2023 | 95.17% |
| December 31, 2022 | 95.17% |
| November 30, 2022 | 94.32% |
| October 31, 2022 | 94.23% |
| Date | Value |
|---|---|
| September 30, 2022 | 94.23% |
| August 31, 2022 | 94.23% |
| July 31, 2022 | 94.23% |
| June 30, 2022 | 94.23% |
| May 31, 2022 | 94.23% |
| April 30, 2022 | 92.81% |
| March 31, 2022 | 92.81% |
| February 28, 2022 | 92.81% |
| January 31, 2022 | 92.81% |
| December 31, 2021 | 92.81% |
| November 30, 2021 | 92.81% |
| October 31, 2021 | 92.81% |
| September 30, 2021 | 92.81% |
| August 31, 2021 | 92.81% |
| July 31, 2021 | 92.81% |
| June 30, 2021 | 92.81% |
| May 31, 2021 | 92.81% |
| April 30, 2021 | 92.81% |
| March 31, 2021 | 92.81% |
| February 28, 2021 | 92.81% |
| January 31, 2021 | 92.81% |
| December 31, 2020 | 92.81% |
| November 30, 2020 | 92.81% |
| October 31, 2020 | 92.81% |
| September 30, 2020 | 92.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
92.81%
Minimum
Nov 2019
95.17%
Maximum
Dec 2022
93.88%
Average
93.52%
Median
Max Drawdown (5Y) Benchmarks
| Merck & Co Inc | 27.26% |
| Terns Pharmaceuticals Inc | -- |
| Instil Bio Inc | -- |
| Viking Therapeutics Inc | 89.26% |
| Moderna Inc | 89.10% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 71.81 |
| Beta (5Y) | -0.9184 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 195.3% |
| Historical Sharpe Ratio (5Y) | 0.3069 |
| Historical Sortino (5Y) | 1.197 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.60% |